Prognostic Value of Body Mass Index in Korean Patients With Renal Cell Carcinoma
Received 1 June 2009 published online 14 December 2009.
Refers to article:
Body Mass Index as a Predictor of Urological Disease and Outcomes—Overly Simplistic?
, 14 December 2009
Viraj A. Master
The Journal of Urology
February 2010 (Vol. 183, Issue 2, Pages 427-429) Full Text |
Full-Text PDF (113 KB)
The miR-17-92 Cluster is Over Expressed in and Has an Oncogenic Effect on Renal Cell Carcinoma
, 17 December 2009
Tsz-fung F. Chow, Marina Mankaruos, Andreas Scorilas, Youssef Youssef, Andrew Girgis, Sarah Mossad, Shereen Metias, Yostina Rofael, R. John Honey, Robert Stewart, Kenneth T. Pace, George M. Yousef
The Journal of Urology
February 2010 (Vol. 183, Issue 2, Pages 743-751) Abstract |
Full Text |
Full-Text PDF (868 KB)
Purpose
Whether body mass index is a prognostic factor in patients with renal cell carcinoma continues to be debated. We investigated the association between body mass index, and clinical/pathological features and prognosis in a large cohort of Korean patients with renal cell carcinoma.
Materials and Methods
The medical records of 1,017 patients with renal cell carcinoma who underwent curative surgery between 1988 and 2006 were reviewed. Mean followup was 76.9 months. We analyzed the association of body mass index at surgery with tumor pathological features, and its associations with cancer specific survival and overall survival were evaluated using the Kaplan-Meier method and Cox regression models. Additional survival analysis was performed in a subgroup of 897 patients with T1-4N0M0 disease.
Results
Of the 1,017 patients 363 (35.7%), 526 (51.7%) and 128 (12.6%) had a body mass index of less than 23 (normal), 23 to 27.5 (overweight) and 27.5 or greater (obese) kg/m2, respectively. Overweight and obese patients had less aggressive tumors, such as less lymph node and/or distant metastases (p = 0.001), low pathological T stage (p = 0.047) and low Fuhrman grade (p = 0.033) vs normal weight patients. In terms of cancer specific survival and overall survival multivariate analysis showed that overweight (p = 0.040 and p = 0.047, respectively) and obese (p = 0.024 and p = 0.010, respectively) patients had good survival rates compared to those with a body mass index in the normal range in the cohort (T1-4NallMall) groups. In addition, overweight (p = 0.022 and p = 0.029, respectively) and obese (p = 0.009 and p = 0.002, respectively) status was significantly associated with cancer specific and overall survival in the T1-4N0M0 groups.
Conclusions
Our findings suggest that overweight and obese Korean patients with renal cell carcinoma have more favorable pathological features and a better prognosis than those with a normal body mass index.
cSeoul National University Bundang Hospital, Seongnam, Korea
Correspondence: Department of Urology, Seoul National University Hospital, 28, Yongon-dong, Chongno-gu, Seoul 110-744, Korea (telephone: 82-2-2072-2915; FAX: 82-2-742-4665)
Study received institutional review board approval.
See Editorial on page 427.
For another article on a related topic see page 743.
ABSTRACT